✦ LIBER ✦

Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population

✍ Scribed by Dinh, T. A.; Rosner, B. I.; Atwood, J. C.; Boland, C. R.; Syngal, S.; Vasen, H. F. A.; Gruber, S. B.; Burt, R. W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lynch syndrome screening strategies in l

✍ Rocconi, R.; Scalici, J.; Leath, C.; Finan, M.; Estes, J.; Straughn, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 178 KB

The Cost-Effectiveness and Cost-Benefit

✍ Kraemer, Kevin L. 📂 Article 📅 2007 🏛 Haworth Press Inc 🌐 English ⚖ 540 KB

Assessing the cost-effectiveness of drug

✍ M. Y. Bertram; S. S. Lim; J. J. Barendregt; T. Vos 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 230 KB

Cost-Effectiveness of Systematic Testing

✍ Huxley, N.; Snowsill, T.; Hoyle, M.; Jones-Hughes, T.; Coelho, H.; Cooper, C.; F 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Screening uptake rates and the clinical

✍ O’Dea, Angela; Infanti, Jennifer J; Gillespie, Paddy; Tummon, Olga; Fanous, Samu 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 565 KB

The effectiveness and cost-effectiveness

✍ Simon Coulton; Jude Watson; Martin Bland; Colin Drummond; Eileen Kaner; Christin 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 251 KB